INDIVIOR PLC (INDV)
GB00BN4HT335 - Common Stock
Taking everything into account, INDV scores 4 out of 10 in our fundamental rating. INDV was compared to 196 industry peers in the Pharmaceuticals industry. INDV has a medium profitability rating, but doesn't score so well on its financial health evaluation. INDV scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
INDV had positive earnings in the past year.
INDV had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a decent Return On Assets value of -9.19%, INDV is doing good in the industry, outperforming 73.85% of the companies in the same industry.
INDV has a better Return On Invested Capital (39.88%) than 97.95% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly below the industry average of 39.88%.
The last Return On Invested Capital (39.88%) for INDV is above the 3 year average (24.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.19% | ||
| ROE | N/A | ||
| ROIC | 39.88% |
ROA(3y)2.77%
ROA(5y)1.35%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)24.06%
ROIC(5y)19.44%
1.3 Margins
INDV's Profit Margin has declined in the last couple of years.
The Operating Margin of INDV (23.02%) is better than 90.26% of its industry peers.
In the last couple of years the Operating Margin of INDV has declined.
INDV has a better Gross Margin (83.00%) than 87.69% of its industry peers.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.02% | ||
| PM (TTM) | N/A | ||
| GM | 83% |
OM growth 3Y22.01%
OM growth 5Y-5.65%
PM growth 3YN/A
PM growth 5Y-63.27%
GM growth 3Y-0.77%
GM growth 5Y-0.81%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
INDV has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, INDV has less shares outstanding
Compared to 1 year ago, INDV has an improved debt to assets ratio.
2.2 Solvency
INDV has an Altman-Z score of 1.51. This is a bad value and indicates that INDV is not financially healthy and even has some risk of bankruptcy.
INDV's Altman-Z score of 1.51 is fine compared to the rest of the industry. INDV outperforms 65.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.51 |
ROIC/WACC4
WACC9.96%
2.3 Liquidity
A Current Ratio of 0.85 indicates that INDV may have some problems paying its short term obligations.
INDV's Current ratio of 0.85 is on the low side compared to the rest of the industry. INDV is outperformed by 89.74% of its industry peers.
A Quick Ratio of 0.68 indicates that INDV may have some problems paying its short term obligations.
With a Quick ratio value of 0.68, INDV is not doing good in the industry: 88.72% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -125.98%.
Measured over the past years, INDV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.67% on average per year.
The Revenue has grown by 14.36% in the past year. This is quite good.
INDV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.69% yearly.
EPS 1Y (TTM)-125.98%
EPS 3YN/A
EPS 5Y-64.67%
EPS Q2Q%12.82%
Revenue 1Y (TTM)14.36%
Revenue growth 3Y19.1%
Revenue growth 5Y1.69%
Sales Q2Q%8.33%
3.2 Future
INDV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.58% yearly.
INDV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.27% yearly.
EPS Next Y31.05%
EPS Next 2Y23.87%
EPS Next 3Y24.63%
EPS Next 5Y26.58%
Revenue Next Year10.15%
Revenue Next 2Y6.98%
Revenue Next 3Y8.28%
Revenue Next 5Y11.27%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 6.02, which indicates a rather cheap valuation of INDV.
Based on the Price/Earnings ratio, INDV is valued cheaper than 96.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of INDV to the average of the S&P500 Index (30.57), we can say INDV is valued rather cheaply.
The Price/Forward Earnings ratio is 4.45, which indicates a rather cheap valuation of INDV.
Based on the Price/Forward Earnings ratio, INDV is valued cheaply inside the industry as 97.44% of the companies are valued more expensively.
INDV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.02 | ||
| Fwd PE | 4.45 |
4.2 Price Multiples
INDV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INDV is cheaper than 98.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.44 |
4.3 Compensation for Growth
INDV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as INDV's earnings are expected to grow with 24.63% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y23.87%
EPS Next 3Y24.63%
5. Dividend
5.1 Amount
No dividends for INDV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INDIVIOR PLC
NASDAQ:INDV (9/17/2024, 5:20:02 PM)
After market: 9.51 0 (0%)9.51
-0.03 (-0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.25B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.02 | ||
| Fwd PE | 4.45 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.19% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 23.02% | ||
| PM (TTM) | N/A | ||
| GM | 83% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.75
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-125.98%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y31.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.36%
Revenue growth 3Y19.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y